Skip to main content

Healthcare Solutions

Flu vaccine helps reduce hospitalizations due to influenza pneumonia: study

Oct. 6, 2015—More than half of hospitalizations due to influenza pneumonia could be prevented by influenza vaccination, according to a study led by investigators at Vanderbilt University Medical Center, published this week in the Journal of the American Medical Association.

Read more


Collaboration seeks to develop new therapies for bone, other diseases

Oct. 1, 2015—La Jolla Pharmaceutical Co. and Vanderbilt University have signed a research and license agreement covering Vanderbilt’s research program and intellectual property rights related to compounds that block bone morphogenetic protein (BMP) type-I receptors. The compounds have therapeutic potential in a broad range of diseases, including rare genetic disorders.

Read more


Infants born with NAS more likely to be readmitted: Study

Oct. 1, 2015—Infants diagnosed with drug withdrawal symptoms at birth, also known as neonatal abstinence syndrome (NAS), are nearly 2.5 times as likely to be readmitted to the hospital in the first month after being discharged compared with full-term infants born without complications, according to new Vanderbilt research released in the journal Hospital Pediatrics.

Read more


VICC investigators land Komen breast cancer grants

Oct. 1, 2015—Two Vanderbilt-Ingram Cancer Center (VICC) investigators — Jennifer Pietenpol, Ph.D., B.F. Byrd Jr. Professor of Oncology and director of VICC, and Valerie Jansen, M.D., Ph.D., medical oncology fellow — have received new cancer research grants awarded by Susan G. Komen, the world’s largest nonprofit funder of breast cancer research.

Read more


An update from Chancellor Zeppos on the 2015-16 academic year

Sep. 28, 2015—"As we officially transition into fall, many great accomplishments have already been achieved that will distinguish and define the 2015-16 academic year and Vanderbilt’s history," writes Chancellor Nicholas S. Zeppos in a message to the Vanderbilt community Sept. 28.

Read more


Team to explore using nanoparticles to fight cancer

Sep. 24, 2015—Three Vanderbilt researchers have received a federal grant to study the use of nanoparticles to deliver potential therapies for breast cancer that has spread to the bone.

Read more


Study tracks brain’s trigger for overeating high-fat food

Sep. 24, 2015—Disruptions in a specific signaling pathway in the brain can cause overeating of high-fat food, researchers at Vanderbilt University have found.

Read more


Stallworth makes select list of brain injury rehab centers

Sep. 24, 2015—Vanderbilt Stallworth Rehabilitation Hospital’s performance at helping people with traumatic brain injuries reconnect with their lives has received Joint Commission recognition and is now one of only seven rehab centers to achieve specialty accreditation for “traumatic brain injury rehabilitation.”

Read more


Cancer therapies’ impact on heart, kidneys explored

Sep. 24, 2015—Vanderbilt is embarking on a multi-disciplinary approach to understand how promising cancer treatments, specifically certain kinase inhibitors, affect the heart and kidneys.

Read more


Survivors of Ebola outbreak take part in VUMC vaccine study

Sep. 24, 2015—Two survivors of a 2014 Ebola outbreak in Nigeria visited Vanderbilt University Medical Center last week to share their experiences and participate in a study aimed at finding ways to treat the often-fatal infection.

Read more


Sound waves studied to help diagnose concussion

Sep. 24, 2015—Researchers at the Vanderbilt Sports Concussion Center (VSCC) are using novel sound wave technology as part of an attempt to more rapidly and accurately diagnose sports concussions on the sidelines during games.

Read more


Discovery Lecture explores health care cost controls

Sep. 17, 2015—“There’s no magic bullet” to control rising health care costs in the United States, health law expert Timothy Jost, J.D., said during last week’s Flexner Discovery Lecture.

Read more


Upcoming Events

MORE EVENTS »